APD356
Showing 1 - 20 of 20
Obesity Trial in Baton Rouge (APD356)
Completed
- Obesity
- APD356
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 11, 2019
Obesity Trial in Baton Rouge (APD356)
Completed
- Obesity
- APD356
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 11, 2019
Obesity Trial in San Diego (Lorcaserin 10 mg once daily (QD), Lorcaserin 10 mg twice a day (BID), Matching Placebo)
Completed
- Obesity
- Lorcaserin 10 mg once daily (QD)
- +2 more
-
San Diego, CaliforniaArena Pharmaceuticals, Inc.
Sep 19, 2019
Obesity Trial in San Diego (Lorcaserin 10 mg once daily (QD), Lorcaserin 10 mg twice a day (BID), Matching Placebo)
Completed
- Obesity
- Lorcaserin 10 mg once daily (QD)
- +2 more
-
San Diego, CaliforniaArena Pharmaceuticals, Inc.
Sep 19, 2019
Obesity Trial in San Diego (Lorcaserin 10 mg BID, Matching Placebo BID)
Completed
- Obesity
- Lorcaserin 10 mg BID
- Matching Placebo BID
-
San Diego, CaliforniaArena Pharmaceuticals, Inc.
Sep 19, 2019
Healthy Participants Trial in San Antonio (Lorcaserin manufactured at Zofingen, Lorcaserin manufactured at Kawashima)
Completed
- Healthy Participants
- Lorcaserin manufactured at Zofingen
- Lorcaserin manufactured at Kawashima
-
San Antonio, TexasWorldwide Clinical Trials
Oct 16, 2018
Osteopenia, Osteoporosis Trial in Minneapolis, Seattle (Pamidronate, Calcium and vitamin D)
Completed
- Osteopenia
- Osteoporosis
- Pamidronate
- Calcium and vitamin D
-
Minneapolis, Minnesota
- +1 more
Dec 8, 2022
Smoking Cessation Trial in United States (APD356-lorcaserin HCl, Placebo)
Completed
- Smoking Cessation
- APD356-lorcaserin hydrochloride
- Placebo
-
Encino, California
- +30 more
Mar 27, 2019
Obesity Trial in Willingboro (Lorcaserin 10mg)
Completed
- Obesity
- Lorcaserin 10mg
-
Willingboro, New JerseyCRI Worldwide
Sep 11, 2019
Hepatic Impairment Trial in Orlando (Lorcaserin)
Completed
- Hepatic Impairment
-
Orlando, FloridaOrlando Clinical Research Center
Sep 11, 2019
Renal Impairment Trial in Orlando (Lorcaserin 10mg)
Completed
- Renal Impairment
- Lorcaserin 10mg
-
Orlando, FloridaOrlando Clinical Research Center
Sep 11, 2019
Obesity Trial in Baton Rouge (Placebo, Lorcaserin 10mg BID)
Completed
- Obesity
- Placebo
- Lorcaserin 10mg BID
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 11, 2019
Obesity Trial in United States (lorcaserin HCl XR, Placebo)
Terminated
- Obesity
- lorcaserin hydrochloride XR
- Placebo
-
Phoenix, Arizona
- +15 more
Jun 29, 2021
Drug Abuse, Healthy Trial in Toronto (Placebo, Active Comparator #1, Active Comparator #2)
Completed
- Drug Abuse
- Healthy
- Placebo
- +6 more
-
Toronto, Ontario, CanadaKendle Early Phase, Toronto
Sep 11, 2019
Pharmacokinetics in Obese Adolescents Trial in Philadelphia, San Antonio (Lorcaserin)
Completed
- Pharmacokinetics in Obese Adolescents
-
Philadelphia, Pennsylvania
- +1 more
Sep 16, 2019
Chronic Weight Management Trial in United States (lorcaserin + phentermine , lorcaserin + phentermine-HCl + phentermine ,
Completed
- Chronic Weight Management
- lorcaserin + phentermine placebo
- +2 more
-
Birmingham, Alabama
- +12 more
Sep 27, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Healthy Subjects Trial in Toshima-Ku (APD356 10 mg, APD356 XR-20 mg, APD356 10 mg matching Placebo)
Completed
- Healthy Subjects
- APD356 10 mg
- +7 more
-
Toshima-Ku, Tokyo, Japan(unnamed)
Feb 8, 2016
Obesity Trial in Anaheim (Lorcaserin HCl)
Completed
- Obesity
- Lorcaserin hydrochloride
-
Anaheim, CaliforniaAnaheim Clinical Trials
Nov 2, 2015